No Data
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture
TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Maintains Target Price $10
TD Cowen Initiates Ginkgo Bioworks(DNA.US) With Buy Rating, Announces Target Price $10
Ginkgo Bioworks Holdings: A Buy Rating on Strategic AI Advancements and Market Expansion
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development